During the past decade, Hospital Italiano de Cordoba conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 9 clinical trials were completed, i.e. on average, 128.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Italiano de Cordoba" #1 sponsor was "Actelion" with 3 trials, followed by "United Therapeutics" with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Telik" with 2 trials sponsored and "Argentinian Intensive Care Society" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Italiano de Cordoba" #1 collaborator was "ARTTIC International Management Services" with 1 trials as a collaborator, "CIMAB (Cuba)" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Eurofarma Laboratorios S.A." with 1 trials as a collaborator and "Federación Argentina de Cardiología FAC" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Italiano de Cordoba" are "Pulmonary Arterial Hypertension" (5 trials), "Pulmonary Hypertension" (3 trials), "Rheumatoid Arthritis" (3 trials), "Cardiovascular Diseases" (2 trials) and "Connective Tissue Diseases" (2 trials). Many other conditions were trialed in "Hospital Italiano de Cordoba" in a lesser frequency.

Most popular intervention types in "Hospital Italiano de Cordoba" are "Drug" (18 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Ralinepag" (2 trials), "ART-123" (1 trials), "Baricitinib" (1 trials) and "Best Support Treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Italiano de Cordoba" are 20 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Italiano de Cordoba". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 14 completed trials in Hospital Italiano de Cordoba, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Italiano de Cordoba, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".